Terns Pharmaceuticals (TERN) has released an update to notify the public and investors about a regulation fd disclosure.
Terns has recently announced the exciting appointment of Ms. Burroughs as its new Chief Executive Officer and her addition to the company’s Board. This strategic move is set to bring fresh leadership to Terns and could signify a new direction for the company’s future, making it a point of interest for stock market enthusiasts and investors keeping an eye on corporate developments.
For further insights into TERN stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.